Rebecca Richards, MD/PHD
Basic profileAssistant Professor, Pediatric Hematology, Oncology & Bone Marrow Transplant School of Medicine and Public Health · University of Wisconsin–Madison
Rebecca Richards is Assistant Professor, Pediatric Hematology, Oncology & Bone Marrow Transplant School of Medicine and Public Health at University of Wisconsin–Madison. OpenAlex indexes 56 publications with 2,694 citations (h-index 13).
Overview
Updated 27 Oct 2026
Rebecca Richards, MD/PHD, is Assistant Professor, Pediatric Hematology, Oncology & Bone Marrow Transplant School of Medicine and Public Health at University of Wisconsin–Madison. The public record shows 64 publications with 3,442 citations (h-index 13), centered on CAR-T cell therapy research, Immunotherapy and Immune Responses, Glioma Diagnosis and Treatment. It also documents an investigator role on 4 registered clinical trials, industry payments reported by 1 companies, 1 NIH-funded awards (2022–2026).
- Most recent indexed publication: 2026 · Veterinary and comparative oncology
- Top research focus: CAR-T cell therapy research
- 4 registered trials on ClinicalTrials.gov
- Open Payments reporting from 1 companies
Generated from the cited public record · current as of 27 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 17.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Industry payments
Updated 27 Oct 2026
1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Chiesi USA, Inc.Program year20251 payment
NIH funding
Updated 27 Oct 2026
1 NIH research award on record, funded 2022–2026 per NIH RePORTER. The latest:
- The Center for Innovation and Translation of Point of Care Technologies for Expanded Cancer Care Access (CITEC)
Rice University
FY2026$1,261,456U54EB034652 - Deep learning microscope for slide-free and digital histology
Rice University
FY2026$708,207R01DE032051 - The AVANÇO Research Consortium: A Mozambique/Brazil/Texas Alliance to advance novel and affordable technologies for the prevention and diagnosis of cervical cancer in women living with HIV
University of Tx Md Anderson Can Ctr
FY2026$647,819U54CA277843
Congress activity
Updated 27 Oct 2026
7 congress contributions (2020–2024) across AACR, ASH per OpenAlex. The most recent:
- CD38-Specific but Not CD19-Specific CAR T Cells Exert Anti-Tumor Activity in Models of Primary Effusion Lymphoma (PEL)
ASH Annual Meeting
ASH2024Co-author - Optimizing the IFNγ Axis Improves CAR T-Cell Potency in AML but Not B-ALL
ASH Annual Meeting
ASH2024Co-author - Abstract 959: Immune signatures of GD2 CAR T cell activity in H3K27M+ diffuse midline glioma patients
AACR Annual Meeting
AACR2023Co-author
Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.
Publications
Updated 27 Oct 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Safety and Feasibility of Infusing Ex Vivo Expanded Allogeneic Canine Natural Killer Cells for the Treatment of Metastatic Solid Tumours.
Veterinary and comparative oncology
Article2026 - Conditional lethality profiling reveals anticancer mechanisms of action and drug-nutrient interactions.
Science advances
Article2024
Most-cited works
by citation count (OpenAlex)- 01GD2-CAR T cell therapy for H3K27M-mutated diffuse midline gliomasArticle831 citations2022
- 02Tuning the Antigen Density Requirement for CAR T-cell ActivityArticle582 citations2020
- 03Cytomegalovirus Vectors Violate CD8 + T Cell Epitope Recognition ParadigmsArticle433 citations2013
- 04
- 05Evasion of CD8 + T Cells Is Critical for Superinfection by CytomegalovirusArticle265 citations2010
Network
Updated 27 Oct 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 27 Oct 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/rebecca-richards-md
verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗
Mentions by others
where others cite or feature them- Other
immunology.wisc.edu/staff/richards-md-phd-becky
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →immunology.wisc.edu ↗ - Other
uwhealth.org/providers/rebecca-richards-md-phd
verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →uwhealth.org ↗ - Other
pediatrics.wisc.edu
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →pediatrics.wisc.edu ↗ - Other
pediatrics.wisc.edu
verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →pediatrics.wisc.edu ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 27 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →pediatrics.wisc.edu ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →uwhealth.org ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →uwhealth.org ↗
Editorial & leadership roles
journal and society appointments- Member
St. Baldrick's Foundation, Empowering Pediatric Immunotherapies for Childhood Cancer (EPICC) team
verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →experts.news.wisc.edu ↗
Awards & honors
honors on the public record- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →pediatrics.wisc.edu ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →pediatrics.wisc.edu ↗
- Borden Immunotherapy Pilot Grant
UW Carbone Cancer Center (with Joshua Brockman, PhD), December 2025
2025provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →pediatrics.wisc.edu ↗ - verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →experts.news.wisc.edu ↗
- verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →experts.news.wisc.edu ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →pediatrics.wisc.edu ↗
Secondary affiliations
appointments beyond the home institution- Assistant professor
University of Wisconsin School of Medicine and Public Health
verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →uwhealth.org ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Justine Bruce, MD
University of Wisconsin–Madison
Mark Albertini, MD
University of Wisconsin–Madison
Anne Traynor, MD
University of Wisconsin–Madison
Bryn Webb, MD
University of Wisconsin–Madison
Carl June, MD
University of Pennsylvania
Rainer Storb
University of Washington
Christina Fitzmaurice, MD
Larry Norton, MD
Memorial Sloan Kettering Cancer Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”